153 related articles for article (PubMed ID: 35178446)
1. Ajuba Overexpression Promotes Breast Cancer Chemoresistance and Glucose Uptake through TAZ-GLUT3/Survivin Pathway.
Li X; Zhao G; Mi X; Xu T; Li X; Liu B
Biomed Res Int; 2022; 2022():3321409. PubMed ID: 35178446
[TBL] [Abstract][Full Text] [Related]
2. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
[TBL] [Abstract][Full Text] [Related]
3. AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer.
Bi L; Ma F; Tian R; Zhou Y; Lan W; Song Q; Cheng X
Gene; 2018 Feb; 644():148-154. PubMed ID: 29126926
[TBL] [Abstract][Full Text] [Related]
4. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
[TBL] [Abstract][Full Text] [Related]
5. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
Tanaka I; Osada H; Fujii M; Fukatsu A; Hida T; Horio Y; Kondo Y; Sato A; Hasegawa Y; Tsujimura T; Sekido Y
Oncogene; 2015 Jan; 34(1):73-83. PubMed ID: 24336325
[TBL] [Abstract][Full Text] [Related]
6. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
[TBL] [Abstract][Full Text] [Related]
7. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
[TBL] [Abstract][Full Text] [Related]
8. The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells.
Xu B; Li Q; Chen N; Zhu C; Meng Q; Ayyanathan K; Qian W; Jia H; Wang J; Ni P; Hou Z
Nucleic Acids Res; 2019 Mar; 47(5):2322-2335. PubMed ID: 30597111
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling.
Wang X; Chen Y; Liu W; Liu T; Sun D
J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581
[TBL] [Abstract][Full Text] [Related]
10. Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma.
Zhang C; Wei S; Sun WP; Teng K; Dai MM; Wang FW; Chen JW; Ling H; Ma XD; Feng ZH; Duan JL; Cai MY; Xie D
Theranostics; 2020; 10(20):9066-9082. PubMed ID: 32802179
[No Abstract] [Full Text] [Related]
11. Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
Meneses AM; Medina RA; Kato S; Pinto M; Jaque MP; Lizama I; García Mde L; Nualart F; Owen GI
J Cell Physiol; 2008 Jan; 214(1):110-6. PubMed ID: 17559076
[TBL] [Abstract][Full Text] [Related]
12. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
13. AJUBA promotes the migration and invasion of esophageal squamous cell carcinoma cells through upregulation of MMP10 and MMP13 expression.
Shi X; Chen Z; Hu X; Luo M; Sun Z; Li J; Shi S; Feng X; Zhou C; Li Z; Yang W; Li Y; Wang P; Zhou F; Gao Y; He J
Oncotarget; 2016 Jun; 7(24):36407-36418. PubMed ID: 27172796
[TBL] [Abstract][Full Text] [Related]
14. Knockout of Ajuba Attenuates the Growth and Migration of Hepatocellular Carcinoma Cells.
Le Y; He Y; Bai M; Wang Y; Wu J; Yu L
Cytogenet Genome Res; 2020; 160(11-12):650-658. PubMed ID: 33640888
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
16. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
[TBL] [Abstract][Full Text] [Related]
17. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
18. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
20. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
Xu B; Li Q; Zhang J; Chen F
Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
